Skip to main content

Table 1 Demographic, clinical, laboratory findings of patients on admission

From: The role of SARC-F scale in predicting progression risk of COVID-19 in elderly patients: a prospective cohort study in Wuhan

Characteristics Total(n = 114) Low risk of Sarcopenia (n = 76) High risk of sarcopenia (n = 38) p value
Age, Years 69.52 ± 7.25 68.93 ± 7.00 72.05 ± 8.36 0.038
Sex
 Female 57(50.00%) 38(50.00%) 19(50.00%) 1.000
 Male 57(50.00%) 38(50.00%) 19(50.00%)
Body Mass Index 23.46 ± 3.18 23.57 ± 3.23 23.20 ± 3.08 0.576
Smoking 19(16.67%) 12(15.79%) 7(18.42%) 0.722
Comorbidity
 Hypertension 57(50.00%) 37(48.68%) 20(52.63%) 0.691
 Diabetes 20(17.54%) 14(18.42%) 6(15.79%) 0.728
 Coronary heart disease 10(8.77%) 4(5.26%) 6(15.79%) 0.061
 Stroke 6(5.26%) 2(2.63%) 4(10.53%) 0.075
 Cancer 9(7.89%) 7(9.21%) 2(5.26%) 0.461
 Chronic pulmonary disease 14(12.28%) 8(10.52%) 6(15.79%) 0.420
 Chronic kidney disease 7(6.14%) 4(5.26%) 3(7.89%) 0.581
Symptoms
 Fever 87(76.32%) 60(78.95%) 27(71.05%) 0.350
 Fatigue 66(52.63%) 38(50.00%) 28(73.68%) 0.019
 Myalgia 10(8.77%) 6(7.89%) 4(10.53%) 0.640
 Pharyngalgia 4(3.51%) 3(3.95%) 1(2.63%) 0.710
 Dry cough 72(63.16%) 47(61.84%) 25(65.79%) 0.680
 Expectoration 37(32.46%) 24(31.58%) 13(34.21%) 0.777
 Hemoptysis 5(4.39%) 4(5.26%) 1(2.63%) 0.518
 Dyspnea 46(40.35%) 24(31.58%) 22(57.89%) 0.007
 Chest pain 4(3.51%) 2(2.63%) 2(5.26%) 0.472
 Anorexia 69(60.53%) 41(53.95%) 28(73.68%) 0.042
 Diarrhea 12(10.53%) 9(11.84%) 3(7.89%) 0.517
 Nausea 11(9.65%) 6(7.89%) 5(13.16%) 0.370
Laboratory findings
 White blood cell count (× 109/L) 6.50(5.28–8.52) 6.48(5.34–8.51) 6.85(4.89–9.72) 0.016
 Neutrophil count (×109/L) 4.19(3.01–5.91) 4.78(3.40–5.95) 5.14(3.46–8.59) 0.002
 Lymphocyte count (×109/L) 0.82(0.58–1.13) 0.90(0.66–1.35) 0.69(0.52–1.12) 0.002
 Platelet (×109/L) 204.00(161.00–265.00) 199.00(171.00–261.00) 215.50(152.00–270.50) 0.766
 Hemoglobin, g/L 120.00 ± 20.91 116.87 ± 21.06 126.50 ± 18.46 0.018
 Albumin, g/L 34.90(32.10–37.45) 34.10(32.20–36.50) 36.85(32.30–38.25) 0.147
 Creatinine, μmol/L 65.00(53.00–79.00) 61.00(53.00–82.00) 65.00(49.00–73.00) 0.274
 D-Dimer, mg/L 1.55(0.69–4.65) 1.07(0.56–2.47) 2.23(1.17–7.80) 0.013
 C-reactive protein, mg/L 59.10(21.30–110.20) 61.30(21.30–110.70) 53.05(21.75–99.00) 0.651
 Procalcitonin, ng/mL 0.09(0.06–0.21) 0.07(0.05–0.22) 0.10(0.06–0.18) 0.003
 BNP, pg/mL 270.50(135.00–661.00) 266.80(122.70–457.50) 348.40(159.50–813.70) 0.027
 CD + 3, count/μl 518.00(317.00–804.00) 538.00(345.00–850.00) 432.00(235.00–707.00) 0.007
 CD + 4, count/μl 348.00(212.00–513.00) 378.00(230.00–559.00) 277.00(150.50–476.50) 0.006
 CD + 8, count/μl 167.00(81.00–279.00) 193.00(94.00–258.00) 122.50(76.00–285.00) 0.013
  1. Data are median (IQR), n (%). p values were calculated by Mann-Whitney U test, χ2 test, or Fisher’s exact test, as appropriate
  2. Abbreviations: BNP Brain Natriuretic Peptide